Uncategorized Archives - Page 34 of 252

MondayOct 24, 2022 9:00 am

Advanced Container Technologies Inc. (ACTX) Leaders Talk Game-Changing Microfarm Growing Option on Episode of Leading Podcast

ACTX CEO Doug Heldoorn, Grow Pod inventor Shannon Illingworth discuss the innovative microfarm option on recent Gamechangers LIVE podcast Discussion focuses on history of company, significant health and safety benefits of Grow Pods Company is dedicated to developing, manufacturing and selling advanced cultivation equipment and packaging systems Advanced Container Technologies (OTC: ACTX) chair and CEO Doug Heldoorn was a featured guest on a recent episode of the Gamechangers LIVE podcast (https://cnw.fm/3xv5t). Heldoorn was joined by Shannon Illingworth, inventor of Grow Pods, the microfarm containers that ACTX distributes throughout the United States. During the podcast, the two men discussed the origins…

WednesdayOct 19, 2022 12:00 pm

REZYFi, Inc. In Great Position as Efforts to Enrich Marijuana Jurisprudence Gain Steam

REZYFi is a mortgage origination and specialized financing company with a primary focus on providing senior loans and project financings to state-licensed operators in the cannabis industry The company operates through two wholly owned subsidiaries, REZYFi Lending and ResMac REZYFi is in a position to benefit from recent efforts by the Biden administration and the U.S. Congress to reschedule and decriminalize marijuana, respectively, with the moves expected to boost the cannabis industry The SAFE Banking Act of 2021 and MORE Act have passed the U.S. House of Representatives and are awaiting debate in the Senate; the two bills, if passed…

WednesdayOct 19, 2022 11:15 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Using Novel DehydraTECH(TM) Technology to Address Unmet Antihypertension Drug Market

Research has shown that co-occurring conditions may be linked to high blood pressure, including bone aging and mental illness The antihypertension drug market is anticipated to rise due to the launch of novel pharmaceuticals and diagnostic agents Valued at US $30.2 billion in 2021, the market is expected to grow at a CAGR of 3%, resulting in a value of US $40 billion by 2031 Lexaria’s patented DehydraTECH(TM) technology offers higher bioavailability of active pharmaceutical ingredients due to, in part, bypassing first-pass-liver processing, improving the speed of onset, and brain absorption The American Heart Association (“AMA”) refers to high blood…

WednesdayOct 19, 2022 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Building Portfolio of Brands that Resonates with End Consumers as It Targets Margins and Profitability

Flora Growth is a global cannabis company building a connected, design-led collective of plant-based wellness and lifestyle brands The company’s portfolio of brands is designed to deliver the most compelling customer experiences in the world Through its M&A strategy, Flora Growth has brought on board brands like JustCBD, Vessel Brands Inc., Masaya, No Cap Hemp Co., and Mambe Flora hopes to establish meaningful connections with consumers through these brands, which will enable it to increase its margins and profitability The cannabis industry has gone global, undergoing a sea change in commercialization, normalization, and liberalization. According to a report by New…

MondayOct 17, 2022 9:45 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Drug Development Program Seeking to Provide Safe, Well-Tolerated, Effective Antihypertensive Medication Amid Continued Reports of Suboptimal Adherence to Existing Treatments

Lexaria Bioscience, a global innovator in drug delivery technology, has developed a potential treatment for hypertension using the company’s patented DehydraTECH(TM) platform, now shown in several human studies to reduce blood pressure and arterial stiffness Lexaria’s antihypertensive drug development program comes at a time when researchers are documenting poor control of hypertension among both men and women, partly due to suboptimal adherence to existing antihypertension medication Reasons advanced for the suboptimal adherence include lack of awareness or treatment, increased number of prescribed medications, and major adverse effects of the prescribed drugs Lexaria has so far shown that its DehydraTECH-CBD is…

MondayOct 17, 2022 9:00 am

Changing Legal Landscape for Cannabis in Colombia and the U.S. Portends a New Era of Productivity for Flora Growth Corp. (NASDAQ: FLGC)

Colombia and the United States have both recently exhibited new openness to the possibility of decriminalizing adult recreational cannabis use through legislative change Cannabis supplier Flora Growth cultivates its product at a key Colombian farm and provides it to international markets, and may see additional opportunities arise as cannabis policies advance in the two countries Flora Growth recently announced completion of its first shipments of high-CBD dried cannabis flower to Switzerland and the Czech Republic, as well as CBD isolate supplied to its market in the United States The company also recently reported a 604 percent YOY increase in revenues…

ThursdayOct 13, 2022 9:45 am

Lift&Co. Expo Cannabis Business Conference & Trade Show Releases Limited All-Access Presale Tickets for Vancouver 2023

Canada’s leading Cannabis Conference and Trade Show, Lift&Co. Expo, invites all members of the cannabis industry and community to its upcoming Vancouver event taking place January 12-14, 2023, at the Vancouver Convention Centre. For a limited time, Lift&Co. Expo is releasing a limited number of discounted Lift Cannabis Business Conference (“LCBC”) + Expo All-Access presale tickets for $350 (regularly priced at $599). Starting on day one, the Lift Cannabis Business Conference will tackle timely industry topics such as cannabis blockchain, brand and retailer relations, and cannabis real estate investing. It will also explore laws and regulations that need to change…

ThursdayOct 13, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Using Patented DehydraTECH(TM) Technology to Fight America’s Silent Killer – Hypertension

Three out of four adults living with hypertension do not have the condition under control, putting them at risk for other serious complications Lexaria’s proposed therapy for hypertension is the highly efficient DehydraTECH-CBD, which has presented with no serious adverse side effects in test participants Dominated by the North American market, the global antihypertension drug market accounted for $22,557 million in 2018 and is expected to reach $28,797 million by 2026 In the United States, over 121.5 million adults are affected by high blood pressure – with statistics stacked against people of color, those with a family history of high…

WednesdayOct 12, 2022 12:00 pm

REZYFi, Inc. Leverages Rapidly Growing Cannabis Industry, Offering Needed Mortgage and Lending Solutions

REZYFi is a specialized financing company in the U.S., originating, structuring, and investing in first mortgage loans and alternative structured financings secured by commercial real estate properties Target markets include licensed and permitted cannabis companies, owners of real estate who lease to cannabis companies, and companies and individual homeowners seeking a variety of real estate-related first and additional mortgage-based financing Currently licensed in 36 states, with plans for expansion into all states, REZYFi is leveraging its experience, a network of independent brokers, and proprietary technology, to enhance its offering within target markets REZYFi operates through two wholly-owned subsidiaries – REZYFi…

TuesdayOct 11, 2022 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Patented DehydraTECH(TM) Technology Offering Solutions to Growing Hypertension Problem Worldwide

Hypertension affects nearly half of all adults in the United States – 47% or 116 million people, some of which are medication-resistant A recent study from the University of Toledo College of Medicine and Life Sciences concluded gut bacteria might be the cause of medication-resistant hypertension – as demonstrated in rats used to conduct the study Lexaria’s patented DehydraTECH(TM) technology offers a viable solution for hypertension drug administration and has been received favorably by the FDA during a pre-Investigational New Drug meeting Hypertension, or high blood pressure, remains one of the world’s most deadly health problems, considered a silent killer…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

Category: Uncategorized